IP Library Granted Patent US 8,198,282
Granted Patent B2
US 8,198,282 · App. 12/647,210 · Granted Jun 12, 2012

Substituted azaquinazolines having an antiviral action

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,198,282
App. No.
12/647,210
Granted
Jun 12, 2012
Kind
B2
Abstract

This invention relates to substituted azaquinazolines, to a process for their preparation, to pharmaceutical compositions containing them, and to their use for the treatment and/or prophylaxis of diseases, especially for use as antiviral agents, in particular against cytomegaloviruses.

Claims (55)

1. A method for treating a human cytomegalovirus infection in a human or animal comprising the step of administering an antivirally effective amount of a compound of the formula (I)

in which

Ar is aryl, in which aryl may be substituted by 1 to 3 substituents, where the substituents are selected independently of one another from the group consisting of alkyl, alkoxy, formyl, hydroxycarbonyl, alkylcarbonyl, alkoxycarbonyl, trifluoromethyl, halogen, cyano, hydroxy, amino, alkylamino, aminocarbonyl, and nitro,

in which alkyl may be substituted by 1 to 3 substituents, where the substituents are selected independently of one another from the group consisting of halogen, amino, alkylamino, hydroxy, and aryl,

or two of the substituents on the aryl form, together with the carbon atoms to which they are bonded, a 1,3-dioxolane, a cyclopentane ring, or a cyclohexane ring, and the optionally present third substituent is selected independently thereof from the group consisting of alkyl, alkoxy, formyl, hydroxycarbonyl, alkylcarbonyl, alkoxycarbonyl, trifluoromethyl, halogen, cyano, hydroxy, amino, alkylamino, aminocarbonyl, and nitro;

Q 1 , Q 2 , Q 3 , and Q 4 are CH or N,

where exactly one of Q 1 , Q 2 , Q 3 and Q 4 are N and the others are simultaneously CH;

R 1 is hydrogen, amino, alkyl, alkoxy, alkylamino, alkylthio, cyano, halogen, nitro, or trifluoromethyl,

R 2 is hydrogen, alkyl, alkoxy, alkylthio, cyano, halogen, nitro, or trifluoromethyl,

R 3 is amino, alkyl, alkoxy, alkylamino, alkylthio, cyano, halogen, nitro, trifluoromethyl, alkylsulphonyl, or alkylaminosulphonyl, or

one of R 1 , R 2 , and R 3 is hydrogen, alkyl, alkoxy, cyano, halogen, nitro, or trifluoromethyl, and the other two form, together with the carbon atoms to which they are bonded, a 1,3-dioxolane, a cyclopentane ring, or a cyclohexane ring;

R 4 is hydrogen or alkyl,

R 5 is hydrogen or alkyl, or

R 4 and R 5 in the piperazine ring are bonded to exactly opposite carbon atoms and form a methylene bridge optionally substituted by 1 to 2 methyl groups;

R 6 is hydrogen, alkyl, alkoxy, alkylthio, formyl, hydroxycarbonyl, aminocarbonyl, alkylcarbonyl, alkoxycarbonyl, trifluoromethyl, halogen, cyano, hydroxy, or nitro; and

R 7 is hydrogen, alkyl, alkoxy, alkylthio, formyl, hydroxycarbonyl, alkylcarbonyl, alkoxycarbonyl, trifluoromethyl, halogen, cyano, hydroxy, or nitro;

or a salt thereof.

2. The method of claim 1 , wherein

Ar is phenyl, in which phenyl may be substituted by 1 to 3 substituents, where the substituents are selected independently of one another from the group consisting of C 1 -C 6 -alkyl, C 1 -C 6 -alkoxy, hydroxycarbonyl, C 1 -C 6 -alkylcarbonyl, C 1 -C 6 -alkoxycarbonyl, trifluoromethyl, fluorine, chlorine, bromine, cyano, hydroxy, amino, C 1 -C 6 -alkylamino, and nitro,

or two of the substituents on the phenyl, together with the carbon atoms to which they are bonded, form a 1,3-dioxolane, a cyclopentane ring, or a cyclohexane ring, and the optionally present third substituent is selected independently thereof from the group consisting of alkyl, alkoxy, formyl, hydroxycarbonyl, alkylcarbonyl, alkoxycarbonyl, trifluoromethyl, halogen, cyano, hydroxy, amino, alkylamino, aminocarbonyl, and nitro;

Q 1 , Q 2 and Q 3 are CH or N,

where always exactly one of Q 1 , Q 2 and Q 3 is N and the others are simultaneously CH;

Q 4 is CH;

R 1 is hydrogen, C 1 -C 3 -alkyl, C 1 -C 3 -alkoxy, C 1 -C 3 -alkylthio, fluorine, or chlorine,

R 2 is hydrogen, C 1 -C 3 -alkyl, C 1 -C 3 -alkoxy, C 1 -C 3 -alkylthio, fluorine, or chlorine,

R 3 is C 1 -C 4 -alkyl, cyano, fluorine, chlorine, nitro, trifluoromethyl, or C 1 -C 3 -alkylsulphonyl, or

one of R 1 , R 2 and R 3 is hydrogen, C 1 -C 3 -alkyl, C 1 -C 3 -alkoxy, cyano, halogen, nitro, or trifluoromethyl, and the other two form together with the carbon atoms to which they are bonded a cyclopentane ring or a cyclohexane ring;

R 4 is hydrogen or methyl;

R 5 is hydrogen;

R 6 is hydrogen, C 1 -C 3 -alkyl, C 1 -C 3 -alkoxy, hydroxycarbonyl, aminocarbonyl, trifluoromethyl, fluorine, chlorine, cyano, hydroxyl, or nitro; and

R 7 is hydrogen, C 1 -C 3 -alkyl, C 1 -C 3 -alkoxy, fluorine, chlorine, cyano, or hydroxy.

3. The method of claim 1 , wherein

Ar is phenyl, in which phenyl may be substituted by 1 to 2 substituents, where the substituents are selected independently of one another from the group consisting of methyl, methoxy, fluorine, and chlorine;

Q 1 , Q 2 and Q 3 are CH or N,

where always exactly one of Q 1 , Q 2 and Q 3 is N, and the others are simultaneously CH;

Q 4 is CH;

R 1 is hydrogen, methyl, methoxy, methylthio, fluorine, or chlorine;

R 2 is hydrogen;

R 3 is methyl, isopropyl, tert-butyl, cyano, fluorine, chlorine, nitro, or trifluoromethyl;

R 4 is hydrogen;

R 5 is hydrogen;

R 6 is hydrogen, aminocarbonyl, fluorine, chlorine, cyano, or hydroxy; and

R 7 is hydrogen.

4. The method of claim 1 , wherein

Ar is phenyl, in which phenyl may be substituted by 1 to 2 substituents, where the substituents are selected independently of one another from the group consisting of methyl, methoxy, fluorine and chlorine;

Q 1 , Q 2 and Q 3 are CH or N;

where always exactly one of Q 1 , Q 2 and Q 3 is N, and the others are simultaneously CH;

Q 4 is CH;

R 1 is hydrogen, methyl, or methoxy;

R 2 is hydrogen;

R 3 is methyl, tert-butyl, chlorine, or trifluoromethyl;

R 4 is hydrogen;

R 5 is hydrogen;

R 6 is hydrogen; and

R 7 is hydrogen.

Assignments (7)
CHANGE OF NAME Recorded Sep 9, 2021
From: AIC246 GMBH & CO. KG
To: AIC246 AG & CO. KG
Reel/Frame 057447/0605 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 2, 2021
From: AICURIS ANTI-INFECTIVE CURES GMBH
To: AIC246 GMBH & CO. KG
Reel/Frame 057371/0159 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 31, 2019
From: AICURIS GMBH & CO. KG
To: AICURIS ANTI-INFECTIVE CURES GMBH
Reel/Frame 048208/0077 →
MERGER Recorded Dec 14, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 025497/0663 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2010
From: WUNBERG, TOBIAS; BAUMEISTER, JUDITH; JESKE, MARIO; SUESSMEIER, FRANK; ZIMMERMANN, HOLGER; HENNINGER, KERSTIN; LANG, DIETER
To: BAYER HEALTHCARE AG
Reel/Frame 025491/0068 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2010
From: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
To: AICURIS GMBH & CO. KG
Reel/Frame 025492/0611 →
MERGER Recorded Dec 14, 2010
From: BAYER HEALTHCARE AG
To: BAYER SCHERING PHARMA AKTIENGESELLSCHAFT
Reel/Frame 025497/0632 →